Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Nickolas Zaller to Opiate Substitution Treatment

This is a "connection" page, showing publications Nickolas Zaller has written about Opiate Substitution Treatment.

 
Connection Strength
 
 
 
3.760
 
  1. Pro G, Hayes C, Brown CC, Goree J, Zaller N. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018. Am J Public Health. 2022 02; 112(S1):S66-S76.
    View in: PubMed
    Score: 0.781
  2. Zaller N, Brinkley-Rubinstein L. MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions. J Addict Med. 2020 12; 14(6):e290-e292.
    View in: PubMed
    Score: 0.721
  3. Pro G, Zaller N. Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings. PLoS One. 2020; 15(2):e0228755.
    View in: PubMed
    Score: 0.681
  4. Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015 Jul 25; 386(9991):350-9.
    View in: PubMed
    Score: 0.492
  5. Zaller N, Mazhnaya A, Larney S, Islam Z, Shost A, Prokhorova T, Rybak N, Flanigan T. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care. Int J Drug Policy. 2015 Jan; 26(1):37-42.
    View in: PubMed
    Score: 0.469
  6. Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.
    View in: PubMed
    Score: 0.148
  7. Larney S, Zaller ND, Rich JD. HIV prevention, treatment, and care for people who inject drugs. J Infect Dis. 2013 Aug 01; 208(3):370-2.
    View in: PubMed
    Score: 0.106
  8. Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abuse Treat. 2013 Aug; 45(2):222-6.
    View in: PubMed
    Score: 0.106
  9. Fu JJ, Zaller ND, Yokell MA, Bazazi AR, Rich JD. Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States. J Subst Abuse Treat. 2013 May-Jun; 44(5):502-5.
    View in: PubMed
    Score: 0.105
  10. Taylor LE, Bowman SE, Chapman S, Zaller N, Stein MD, Cioe PA, Maynard MA, McGovern BH. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):233-7.
    View in: PubMed
    Score: 0.090
  11. Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D. Criminal justice continuum for opioid users at risk of overdose. Addict Behav. 2018 11; 86:104-110.
    View in: PubMed
    Score: 0.037
  12. McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Subst Abus. 2012; 33(1):19-29.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.